Current and Emerging Therapies, discussed by Jack S. Burks, MD
Video production date: June 7, 2014 Location: Atlanta, Ga. At this program : Jack S. Burks, MD and Patricia Pagnotta, MSN,…
Gastro Effects Dog Oral MS Drug Tecfidera
Published: May 30, 2014 DALLAS — Large proportions of patients starting on dimethyl fumarate (Tecfidera) for multiple sclerosis appear to…
Stuart Schlossman
New Data Reinforce Efficacy of TECFIDERA® (Dimethyl Fumarate) in MS Patients with High Disease Activity
April 30, 2014 7:30 AM CAMBRIDGE, Mass.–(BUSINESS WIRE)– New data reinforce the efficacy of TECFIDERA in a wide range of…
Stuart Schlossman
Multiple Sclerosis Drug Tecfidera Becoming Increasingly Available In Twice-Daily Pill Form Worldwide
Posted by: Mike Nace March 25, 2014 For those who suffer with Multiple Sclerosis, often times the only viable treatments that curb symptoms…
Stuart Schlossman
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis
CAMBRIDGE, Mass., Feb 03, 2014 (BUSINESS WIRE) — TECFIDERA® (dimethyl fumarate) has been approved by the European Commission(EC) as a first-line…
Stuart Schlossman
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial
BACK for Discussion: SUMMARY: Background Patients who develop relapsing-remitting multiple sclerosis (MS) present with a first clinical demyelinating event. In…
Stuart Schlossman
Thousands of Multiple Sclerosis patients are getting worse each day
Thousands of Multiple Sclerosis patients are getting worse each day, when currently used medications are not working for them or…
Stuart Schlossman
Genzyme’s MS Drug Aubagio Recommended By National Institute For Health And Care Excellence (NICE)
January 24, 2014 A Petition is found below this article posting – Please read the petition sign and send your…
Stuart Schlossman
Sanofi’s Aubagio Wins Final Approval From U.K. Cost Agency NICE
By Simeon Bennett Jan 21, 2014 Sanofi’s multiple sclerosis drug Aubagio won final approval from the U.K.’s health-cost agency, allowing access…
Stuart Schlossman
EU agency due to give verdict on Teva (ORAL) MS pill this week
December 17, 2013 (Reuters) – European regulators are due to decide this week whether or not to recommend approval of…
Stuart Schlossman
